MeSH Review:
Schizotypal Personality Disorder
Cadenhead,
Light,
Geyer,
Braff,
Buchsbaum,
Trestman,
Hazlett,
Siegel,
Schaefer,
Luu-Hsia,
Tang,
Herrera,
Solimando,
Losonczy,
Serby,
Silverman,
Siever,
Shihabuddin,
Buchsbaum,
Hazlett,
Silverman,
New,
Brickman,
Mitropoulou,
Nunn,
Fleischman,
Tang,
Siever,
McDougle,
Epperson,
Pelton,
Wasylink,
Price,
Siever,
Davis,
- A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder. McDougle, C.J., Epperson, C.N., Pelton, G.H., Wasylink, S., Price, L.H. Arch. Gen. Psychiatry (2000)
- CSF homovanillic acid in schizotypal personality disorder. Siever, L.J., Amin, F., Coccaro, E.F., Trestman, R., Silverman, J., Horvath, T.B., Mahon, T.R., Knott, P., Altstiel, L., Davidson, M. The American journal of psychiatry. (1993)
- Functional impairment in patients with schizotypal, borderline, avoidant, or obsessive-compulsive personality disorder. Skodol, A.E., Gunderson, J.G., McGlashan, T.H., Dyck, I.R., Stout, R.L., Bender, D.S., Grilo, C.M., Shea, M.T., Zanarini, M.C., Morey, L.C., Sanislow, C.A., Oldham, J.M. The American journal of psychiatry. (2002)
- Schizophrenia and schizophrenia-spectrum personality disorders in the first-degree relatives of children with schizophrenia: the UCLA family study. Asarnow, R.F., Nuechterlein, K.H., Fogelson, D., Subotnik, K.L., Payne, D.A., Russell, A.T., Asamen, J., Kuppinger, H., Kendler, K.S. Arch. Gen. Psychiatry (2001)
- Striatal size and relative glucose metabolic rate in schizotypal personality disorder and schizophrenia. Shihabuddin, L., Buchsbaum, M.S., Hazlett, E.A., Silverman, J., New, A., Brickman, A.M., Mitropoulou, V., Nunn, M., Fleischman, M.B., Tang, C., Siever, L.J. Arch. Gen. Psychiatry (2001)
- Borderline and schizotypal personality disorders treated with low-dose thiothixene vs placebo. Goldberg, S.C., Schulz, S.C., Schulz, P.M., Resnick, R.J., Hamer, R.M., Friedel, R.O. Arch. Gen. Psychiatry (1986)
- The pathophysiology of schizophrenia disorders: perspectives from the spectrum. Siever, L.J., Davis, K.L. The American journal of psychiatry. (2004)
- An MRI study of superior temporal gyrus volume in women with schizotypal personality disorder. Dickey, C.C., McCarley, R.W., Voglmaier, M.M., Niznikiewicz, M.A., Seidman, L.J., Demeo, S., Frumin, M., Shenton, M.E. The American journal of psychiatry. (2003)
- Minor physical anomalies, dermatoglyphic asymmetries, and cortisol levels in adolescents with schizotypal personality disorder. Weinstein, D.D., Diforio, D., Schiffman, J., Walker, E., Bonsall, R. The American journal of psychiatry. (1999)
- Plasma homovanillic acid in schizotypal personality disorder. Siever, L.J., Amin, F., Coccaro, E.F., Bernstein, D., Kavoussi, R.J., Kalus, O., Horvath, T.B., Warne, P., Davidson, M., Davis, K.L. The American journal of psychiatry. (1991)
- Fluoxetine in the treatment of borderline and schizotypal personality disorders. Markovitz, P.J., Calabrese, J.R., Schulz, S.C., Meltzer, H.Y. The American journal of psychiatry. (1991)
- Comparison of whole blood serotonin and platelet MAO in children with schizophrenia and major depressive disorder. Rogeness, G.A., Mitchell, E.L., Custer, G.J., Harris, W.R. Biol. Psychiatry (1985)
- D-amphetamine challenge effects on Wisconsin Card Sort Test. Performance in schizotypal personality disorder. Siegel, B.V., Trestman, R.L., O'Flaithbheartaigh, S., Mitropoulou, V., Amin, F., Kirrane, R., Silverman, J., Schmeidler, J., Keefe, R.S., Siever, L.J. Schizophr. Res. (1996)
- Sensory gating deficits assessed by the P50 event-related potential in subjects with schizotypal personality disorder. Cadenhead, K.S., Light, G.A., Geyer, M.A., Braff, D.L. The American journal of psychiatry. (2000)
- Large CSF volume not attributable to ventricular volume in schizotypal personality disorder. Dickey, C.C., Shenton, M.E., Hirayasu, Y., Fischer, I., Voglmaier, M.M., Niznikiewicz, M.A., Seidman, L.J., Fraone, S., McCarley, R.W. The American journal of psychiatry. (2000)
- 3H-spiperone binding to lymphocytes in neuroleptic-naive-schizophrenia and the effect of neuroleptic treatment. Laufer, N., Spivak, B., Holdengreber, V., Zipser, J., Kosower, N., Ragolsky, M., Weizman, A. Clinical neuropharmacology. (1999)
- Attentional functioning in schizotypal personality disorder. Roitman, S.E., Cornblatt, B.A., Bergman, A., Obuchowski, M., Mitropoulou, V., Keefe, R.S., Silverman, J.M., Siever, L.J. The American journal of psychiatry. (1997)
- Auditory P300 does not differentiate borderline personality disorder from schizotypal personality disorder. Kutcher, S.P., Blackwood, D.H., Gaskell, D.F., Muir, W.J., St Clair, D.M. Biol. Psychiatry (1989)
- Regional cerebral blood flow during the Wisconsin Card Sort Test in schizotypal personality disorder. Buchsbaum, M.S., Trestman, R.L., Hazlett, E., Siegel, B.V., Schaefer, C.H., Luu-Hsia, C., Tang, C., Herrera, S., Solimando, A.C., Losonczy, M., Serby, M., Silverman, J., Siever, L.J. Schizophr. Res. (1997)
- Developmental changes in cortisol secretion in normal and at-risk youth. Walker, E.F., Walder, D.J., Reynolds, F. Development and psychopathology. (2001)